Scientific article
Review
OA Policy
French

Alopécie androgénétique : où en est-on en 2024 ?

Other titleAndrogenetic alopecia: where do we stand in 2024?
Published inRevue médicale suisse, vol. 20, no. 867, p. 653-658
Publication date2024-03-27
Abstract

Androgenetic alopecia, the most prevalent type of hair loss, is characterized by a receding hairline in men and diffuse thinning of hair in women. Despite being considered a benign condition, it can exert a considerable psychological toll, especially on women and young men. Despite its high prevalence, only a limited number of medications have received approval for its treatment. In this article, we review the available treatment options, assessing their efficacy and potential side effects. Additionally, we explore minimally-invasive strategies such as photobiomodulation, micro-needling and platelet-rich plasma therapy. Furthermore, we delve into discussions on hair transplantation and camouflage methods.

Keywords
  • Male
  • Humans
  • Female
  • Alopecia / therapy
  • Hair
  • Platelet-Rich Plasma
  • Treatment Outcome
Citation (ISO format)
BERTONE, Federica et al. Alopécie androgénétique : où en est-on en 2024 ? In: Revue médicale suisse, 2024, vol. 20, n° 867, p. 653–658. doi: 10.53738/REVMED.2024.20.867.653
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Journal ISSN1660-9379
269views
1495downloads

Technical informations

Creation30/05/2024 13:55:43
First validation02/10/2024 06:53:57
Update30/10/2024 14:01:45
Status update30/10/2024 14:01:45
Last indexation05/10/2025 00:17:14
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack